The Lupus Alliance of LIQ is committed to supporting scientific and medical lupus research at local and national levels. One of Lupus Alliance of LIQ`s prime accomplishments has been to work collaboratively with the Lupus Research Institute (LRI) in its novel efforts to find better ways to treat and hopefully cure lupus. The Lupus Alliance of LIQ through your generous donations, has contributed over $550,000 to various research initiatives since 2002.


In the last few years, more funding has been directed at lupus research through government, for profit and non-profit organizations. For example, the National Institute of Health allocated $84 million in 2008 to fund lupus-related research. After so many years of under funding and unfocused attention in the research community, these initiatives are very encouraging.


There is a considerable amount of information on the web about lupus research. Keep coming back to our website to check out the latest information on research and related developments.

Elevated IgG Anticardiolipin Rate Linked with Increased Risk of Thrombotic Events in SLE Patients

Patients with systemic lupus erythematous had higher rates of thromboses when they had elevated rates of immunoglobulin G anticardiolipin and lupus anticoagulant, according to this study. Vinicius Domingues, MD, from the Department of Rheumatology at New York University School of Medicine in New York, and colleagues analyzed 1,390 patients in the Hopkins Lupus Cohort with… Read More »

Trigger May Be Uncovered For Lupus, Other Autoimmune Diseases

Scientists at the Hospital for Special Surgery (HSS) in New York, in collaboration with Greek researchers, may have identified a trigger for autoimmune disorders that could shed light on how many diseases develop, including lupus. The investigators found virus-like components of the human genome that seem to be associated with both lupus and Sjogren’s syndrome. The… Read More »

US Appropriations Committee Bill Includes $6 Million for Lupus Education and Research

A bill recently moved forward by the U.S. Senate Appropriations Committee on labor, health human services and education for 2017 includes $6 million for lupus research and education, in addition to $34 billion for medical research overall at the National Institutes of Health (NIH). Specifically, the committee bill supports funding for the Office of Minority Health’s National Health Education… Read More »

Elusive Target: A Rundown of the Drug Pipeline for Systemic Lupus Erythematosus

Systemic lupus erythematosus is a heterogeneous disease that requires a customized approach to its management. Therapies range from nonsteroidal anti-inflammatory drugs to one of any number of immunomodulators or biologics. However, the clinical community has yet to arrive at a perfect therapy or even a perfect combination of therapies. “Every patient with lupus is different,”… Read More »

Benlysta Seems to Cut Flares in Lupus

LONDON — Adding belimumab (Benlysta) to standard treatments for systemic lupus erythematosus was associated with significantly lower rates of disease flares, a claims-based analysis revealed. In an “as treated” analysis, there was an approximately 30% decrease in the incidence rate of moderate-to-severe flares during the 12 months after the initiation of belimumab therapy, according to… Read More »

A New Clue Why Autoimmune Diseases Target Women

Researchers have long searched to understand why diseases like lupus and rheumatoid arthritis disproportionately affect women. Now, findings from the Oklahoma Medical Research Foundation shed some new light. Sjögren’s, lupus, RA and more than 80 other disorders are known as “autoimmune” diseases, conditions in which the immune system becomes unbalanced and turns on the body… Read More »